1. Home
  2. KIO vs NUS Comparison

KIO vs NUS Comparison

Compare KIO & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KIO
  • NUS
  • Stock Information
  • Founded
  • KIO 2011
  • NUS 1984
  • Country
  • KIO United States
  • NUS United States
  • Employees
  • KIO 2400
  • NUS N/A
  • Industry
  • KIO Investment Managers
  • NUS Other Pharmaceuticals
  • Sector
  • KIO Finance
  • NUS Health Care
  • Exchange
  • KIO Nasdaq
  • NUS Nasdaq
  • Market Cap
  • KIO 522.7M
  • NUS 603.4M
  • IPO Year
  • KIO N/A
  • NUS 1996
  • Fundamental
  • Price
  • KIO $11.85
  • NUS $11.02
  • Analyst Decision
  • KIO
  • NUS Hold
  • Analyst Count
  • KIO 0
  • NUS 2
  • Target Price
  • KIO N/A
  • NUS $6.88
  • AVG Volume (30 Days)
  • KIO 136.5K
  • NUS 418.4K
  • Earning Date
  • KIO 01-01-0001
  • NUS 11-06-2025
  • Dividend Yield
  • KIO 10.82%
  • NUS 2.18%
  • EPS Growth
  • KIO N/A
  • NUS N/A
  • EPS
  • KIO N/A
  • NUS 2.03
  • Revenue
  • KIO N/A
  • NUS $1,626,325,000.00
  • Revenue This Year
  • KIO N/A
  • NUS N/A
  • Revenue Next Year
  • KIO N/A
  • NUS $0.98
  • P/E Ratio
  • KIO N/A
  • NUS $5.43
  • Revenue Growth
  • KIO N/A
  • NUS N/A
  • 52 Week Low
  • KIO $10.52
  • NUS $5.32
  • 52 Week High
  • KIO $13.59
  • NUS $14.62
  • Technical
  • Relative Strength Index (RSI)
  • KIO 33.58
  • NUS 49.15
  • Support Level
  • KIO $11.57
  • NUS $10.73
  • Resistance Level
  • KIO $12.50
  • NUS $11.03
  • Average True Range (ATR)
  • KIO 0.14
  • NUS 0.35
  • MACD
  • KIO -0.03
  • NUS 0.00
  • Stochastic Oscillator
  • KIO 29.57
  • NUS 60.89

About KIO KKR Income Opportunities Fund

KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

Share on Social Networks: